Informations bibliographiques
Ligne directriceWHO updated recommendations on HIV clinical management: recommendations for a public health approach
Année de publication2025
Institution émettriceWorld Health Organization
Recommandation
Mise à jour
Use of darunavir/ritonavir and other protease inhibitors in HIV treatment. Atazanavir/ritonavir (ATV/r) or lopinavir/ritonavir (LPV/r) can be used as an alternative boosted protease inhibitor for antiretroviral treatment
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Modérée